End points included within-subject change from baseline in plasma ANP , Nt-proBNP , office BP , and HR at baseline and over 4 h following a single dose of liraglutide ( 0.6 mg ) and after 21 days of liraglutide ( titrated to 1.8 mg ) versus placebo administration .